S. 2276 · 119th Congress

ETHIC Act

Introduced on Jul 15, 2025 by Peter Welch (D-VT). 2 cosponsors, 1 of them from another party. Latest action (Jul 15, 2025): Read twice and referred to the Committee on the Judiciary.

Stage
Introduced
Introduced
Jul 15, 2025
Cosponsors
2
1 from the other party
Policy area
Commerce

Progress

The furthest stage the measure reached. Simple and concurrent resolutions do not go to the President.

  1. Introduced
  2. 2Reported by committee
  3. 3Passed one chamber
  4. 4Passed both chambers
  5. 5Sent to the President
  6. 6Became law

Official title

A bill to address patent thickets.

Summary

The Congressional Research Service has not summarized this measure yet.

Sponsor and cosponsors

Cosponsors by party as of the day they signed on. Original cosponsors signed on the day of introduction.

Peter WelchD-VTSponsor

Democrats · 1

Republicans · 1

Roll calls

Recorded votes on the measure. Most measures move by voice vote or unanimous consent, which record no individual positions.

No recorded roll call on this measure: it moved by voice vote or unanimous consent, or has not reached the floor.

History

Every action as published, oldest first. Roll calls link to how each member voted.

  1. Jul 15, 2025Introduced in Senate
  2. Jul 15, 2025 · SenateRead twice and referred to the Committee on the Judiciary.

Committees

Committees and subcommittees the measure was referred to.

Agencies in its committees' jurisdiction

Analisa's mapping of committee jurisdiction to federal agencies; the bill may touch others, or none of these.

Who lobbied on it

Organizations whose lobbying reports (LD-2) name this measure. Spending is what they reported for those quarters on all issues, not on this measure alone.

  1. COUNCIL FOR INNOVATION PROMOTION (C4IP)9 reports
    $360K reported (all issues)
  2. AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)5 reports
    $50K reported (all issues)
  3. PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA5 reports
    $37M reported (all issues)
  4. The Campaign for Sustainable Rx Pricing5 reports
    $450K reported (all issues)
  5. ASSOCIATION FOR ACCESSIBLE MEDICINES4 reports
    $3.5M reported (all issues)
  6. BIOTECHNOLOGY INNOVATION ORGANIZATION4 reports
    $6.8M reported (all issues)
  7. Campaign for Sustainable Drug Pricing (CSRxP)4 reports
    $200K reported (all issues)
  8. Fresenius Kabi4 reports
    $120K reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 99%
  9. Fresenius Kabi USA LLC4 reports
    $2.5M reported (all issues)Federal contractor: FRESENIUS KABI USA, LLCAI match · 100%
  10. GSK (fka GLAXOSMITHKLINE INC.)4 reports
    $5M reported (all issues)
  11. JOHNSON & JOHNSON SERVICES, INC.4 reports
    $8.9M reported (all issues)
  12. NOVARTIS CORPORATION4 reports
    $8M reported (all issues)Federal contractor: NOVARTIS PHARMACEUTICALS CORPORATION$36.2M in contracts, FY2026AI match · 100%
  13. AMGEN INC.3 reports
    $8.6M reported (all issues)Federal contractor: AMGEN INC.AI match · 99%
  14. Public Citizen3 reports
    $273K reported (all issues)
  15. SANOFI US SERVICES INC3 reports
    $4.6M reported (all issues)
  16. CENTER FOR INDIVIDUAL FREEDOM2 reports
    $20K reported (all issues)
  17. Families USA Foundation, Inc.2 reports
    $15K reported (all issues)
  18. T1INTERNATIONAL USA2 reports
  19. AARP1 report
    $4.1M reported (all issues)
  20. APOTEX CORP.1 report
    $730K reported (all issues)
  21. Bayer Corporation (consolidated report)1 report
    $1.8M reported (all issues)
  22. Chamber of Commerce of the U.S.A.1 report
    $17M reported (all issues)
  23. INTELLECTUAL PROPERTY OWNERS ASSOCIATION1 report
    $50K reported (all issues)
  24. NFIB (National Federation of Independent Business)1 report
    $1.7M reported (all issues)
  25. PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION1 report
    $2.9M reported (all issues)

Reports filed in 2025, 2026.

Sources and method

Every figure on this page traces to these records.

  • Bill status: bills and resolutions, sponsors, actions, subjects and CRS summaries (U.S. Government Publishing Office (GovInfo), from Congress.gov (Library of Congress))GovInfo Bill Status bulk data (Congress.gov; summaries by the Congressional Research Service) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Members of Congress, their terms, committees and identifiers (The @unitedstates project (from the Biographical Directory of the U.S. Congress, the House and the Senate))unitedstates/congress-legislators: legislators, committees and current committee membership · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: CC0 1.0 (public domain dedication)
  • House roll-call votes (Office of the Clerk, U.S. House of Representatives)Office of the Clerk, U.S. House of Representatives, roll-call vote records · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Senate roll-call votes and DW-NOMINATE scores (Voteview (UCLA Department of Political Science))Lewis, Jeffrey B., Keith Poole, Howard Rosenthal, Adam Boche, Aaron Rudkin, and Luke Sonnet (2026). Voteview: Congressional Roll-Call Votes Database. https://voteview.com/ · data current to Oct 3, 2026 · loaded Oct 3, 2026 · license: Free to use with the required citation
  • Lobbying disclosures (LD-1 registrations, LD-2 quarterly reports, LD-203 contribution reports) (Clerk of the U.S. House of Representatives)Clerk of the House, Lobbying Disclosure Act filings (organizations only; lobbyists' names are not loaded) · data current to Oct 6, 2026 · loaded Oct 6, 2026 · license: Public domain (U.S. Government work, 17 U.S.C. § 105)
  • Positions are shown only where a roll call recorded them; voice votes and unanimous consent record none.
  • Money and votes are shown side by side; neither explains the other.